Sarah Weinreich
Psychiatric/Mental Health · Warwick, RINPI 1710614672
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 47.7% of the total.
Across 167 payments — averaging $27.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$538
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$451
- Axsome Therapeutics, Inc.$437
- Vanda Pharmaceuticals Inc.$242
- Neurocrine Biosciences, Inc.$211
- plus $516 from 6 others
What the payments were for
- Food & beverage$4,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 84 | $2,179 |
| Otsuka America Pharmaceutical, Inc. | 27 | $538 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $451 |
| Axsome Therapeutics, Inc. | 12 | $437 |
| Vanda Pharmaceuticals Inc. | 7 | $242 |
| Neurocrine Biosciences, Inc. | 4 | $211 |
| Lundbeck LLC | 11 | $192 |
| Braeburn Inc. | 4 | $191 |
| Corium, LLC | 3 | $59 |
| Bausch Health US, LLC | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Alkermes, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,573 in reported general payments places this provider in the 85th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $308 |
| Diazepam | 13 | $161 |
| Alprazolam | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Warwick
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Deborah HorvitzWarwick$10K
- Alyssa KortschinskyWarwick$8K
- Mark GauthierWarwick$8K
- Cathy KennedyWarwick$4K
- Shaylah SpellmanWarwick$2K
- Brett MichelsonWarwick$1K
- Cindy PatrickWarwick$1K
- Samantha Shawn MarshBradford$639K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.